The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia

The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia

Theory of mind (ToM, the ability to attribute mental states to others) deficit is a frequent finding in neurodegenerative conditions, mediated by a diffuse brain network confirmed by <sup>18</sup>F-FDG-PET and MR imaging, involving frontal, temporal and parietal areas. However, the role...

Full description

Bibliographic Details
Main Authors:	Beatrice Orso, Luigi Lorenzini, Dario Arnaldi, Nicola Girtler, Andrea Brugnolo, Elisa Doglione, Pietro Mattioli, Erica Biassoni, Federico Massa, Enrico Peira, Matteo Bauckneht, Maria I. Donegani, Silvia Morbelli, Flavio Nobili, Matteo Pardini
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Biomedicines
Subjects:	Alzheimer’s disease frontotemporal dementia theory of mind brain network <sup>18</sup>F-FDG-PET social cognition
Online Access:	https://www.mdpi.com/2227-9059/10/3/544

Similar Items

Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)
by: Andrea Brugnolo, et al.
Published: (2021-01-01)

Spectrum of clinical and FDG-PET patterns of patients with frontotemporal dementia (FTD) in a tertiary care hospital
by: Sundar Shanmugam, et al.
Published: (2021-06-01)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
by: Matteo Bauckneht, et al.
Published: (2018-04-01)

Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study
by: Leonie Beyer, et al.
Published: (2021-01-01)

Is There a Role for [<sup>18</sup>F]FDG PET-CT in Staging MALT Lymphoma?
by: Dan Cohen, et al.
Published: (2022-01-01)

Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET
by: Nick Corriveau-Lecavalier, et al.
Published: (2024-01-01)

<sup>18</sup>F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
by: Domenico Albano, et al.
Published: (2023-04-01)

Advances in Molecular Imaging in Infective Endocarditis
by: Katarzyna Holcman, et al.
Published: (2023-02-01)

Pulmonary and Liver Toxocariasis Mimicking Metastatic Tumors in a Patient with Colon Cancer
by: Miju Cheon, et al.
Published: (2023-12-01)

Intense FDG Uptake in the Common Bile Duct Post-ERCP Mimics Acute Infectious Cholangitis
by: Neel P. Mistry, et al.
Published: (2022-12-01)

The Additional Value of <sup>18</sup>F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020
by: Natale Quartuccio, et al.
Published: (2020-05-01)

Choline PET/CT in Multiple Myeloma
by: Charles Mesguich, et al.
Published: (2020-05-01)

CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas
by: Alexander Weich, et al.
Published: (2021-03-01)

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body <sup>18</sup>F-Fluorodeoxyglucose and <sup>89</sup>Zr-Rituximab PET Scans
by: Bart M. de Vries, et al.
Published: (2022-02-01)

Different Uptake of <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG in Lymphadenopathy Caused by Angioimmunoblastic T-Cell Lymphoma in a Patient with Colon Cancer
by: Meiqi Wu, et al.
Published: (2022-09-01)

If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[<sup>18</sup>F]FDG Metabolism
by: Eva-Maria Klebermass, et al.
Published: (2021-09-01)

Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-Cov2 Infection
by: Maria Isabella Donegani, et al.
Published: (2021-03-01)

Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via <sup>18</sup>F-Sodium Fluoride PET/CT Imaging
by: Carmela Nappi, et al.
Published: (2024-01-01)

Clinical Utility of <sup>18</sup>F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis
by: Emmanouil Alevroudis, et al.
Published: (2021-04-01)

Clinical and Radiological Features Predicting Intervertebral Autofusion after Successful Antibiotic Therapy in Pyogenic Vertebral Osteomyelitis
by: Insu Seong, et al.
Published: (2021-07-01)

The Relationship between Brown Adipose Tissue Activity and Neoplastic Status: an <sup>18</sup>F-FDG PET/CT Study in the Tropics
by: Huang Yung-Cheng, et al.
Published: (2011-12-01)

Image Quality and Quantitative PET Parameters of Low-Dose [<sup>18</sup>F]FDG PET in a Long Axial Field-of-View PET/CT Scanner
by: Eduardo Calderón, et al.
Published: (2023-10-01)

Comparison of <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI in Spindle Cell Rhabdomyosarcoma
by: Zhihui Shen, et al.
Published: (2023-09-01)

A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)
by: Alice Laffi, et al.
Published: (2021-12-01)

Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review
by: Elizabeth Katherine Anna Triumbari, et al.
Published: (2022-07-01)

Risk Management in Good Manufacturing Practice (GMP) Radiopharmaceutical Preparations
by: Michela Poli, et al.
Published: (2024-02-01)

What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review
by: Jules Tianyu Zhang-Yin, et al.
Published: (2022-02-01)

New Targets for PET Imaging of Myeloma
by: Mona-Elisabeth Revheim, et al.
Published: (2021-12-01)

The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review
by: Luca Urso, et al.
Published: (2023-04-01)

<sup>18</sup>F-FDG PET Is Not Inferior to <sup>68</sup>Ga-PSMA PET for Detecting Biochemical Recurrent Prostate Cancer with a High Gleason Score: A Head-to-Head Comparison Study
by: Lian Xu, et al.
Published: (2023-12-01)

A Systematic Review on Combined [<sup>18</sup>F]FDG and <sup>68</sup>Ga-SSA PET/CT in Pulmonary Carcinoid
by: Daniela Prosperi, et al.
Published: (2023-05-01)

Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
by: Leandra Piscopo, et al.
Published: (2023-07-01)

Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update
by: Daniela Prosperi, et al.
Published: (2022-11-01)

PET-Based Imaging with <sup>18</sup>F-FDG and <sup>18</sup>F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
by: William Y. Raynor, et al.
Published: (2021-11-01)

Usefulness of <sup>18</sup>F-FDG PET-CT in the Management of Febrile Neutropenia: A Retrospective Cohort from a Tertiary University Hospital and a Systematic Review
by: Andrea Gutiérrez-Villanueva, et al.
Published: (2024-01-01)

Preoperative <sup>18</sup>F-FDG PET/CT in Patients with Presumed Localized Colon Cancer: A Prospective Study with Long-Term Follow-Up
by: Samuel Aymard, et al.
Published: (2024-01-01)

Relationship between Standard Uptake Values of Positron Emission Tomography/Computed Tomography and Salivary Metabolites in Oral Cancer: A Pilot Study
by: Shigeo Ishikawa, et al.
Published: (2020-12-01)

Is Imaging Bacteria with PET a Realistic Option or an Illusion?
by: Shashi B. Singh, et al.
Published: (2023-03-01)

The Prognostic Value of <sup>18</sup>F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review
by: Silvia Taralli, et al.
Published: (2021-12-01)

Place of the <sup>18</sup>F-FDG-PET/CT in the Diagnostic Workup in Patients with Classical Fever of Unknown Origin (FUO)
by: Simon Letertre, et al.
Published: (2021-08-01)